InvestorsHub Logo
Followers 114
Posts 8748
Boards Moderated 0
Alias Born 02/27/2016

Re: None

Tuesday, 05/12/2020 10:33:31 PM

Tuesday, May 12, 2020 10:33:31 PM

Post# of 711755
Please explain the tax accounting issue in Germany which has delayed the issuance of the 3/31/20 10Q.https://www.sec.gov/Archives/edgar/data/1072379/000110465920034145/tm205288-1_10k.htm



https://www.sec.gov/Archives/edgar/data/1072379/000110465920060182/tm2014603d3_nt10q.htm

"Northwest Biotherapeutics, Inc. (the “Company”) is unable to file its Quarterly Report on Form 10-Q timely due to unanticipated accounting complications related to a German tax issue. The Company is working with its auditor, Marcum LLP, to address the issue."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News